NHS National Framework for Transition products commencing 1 October 2024
A Contract Award Notice
by NHS ENGLAND
- Source
- Find a Tender
- Type
- Framework (Supply)
- Duration
- 20 month (est.)
- Value
- £44M
- Sector
- HEALTH
- Published
- 17 Oct 2024
- Delivery
- 01 Oct 2024 to 31 May 2026 (est.)
- Deadline
- n/a
Concepts
Location
Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points
2 buyers
- NHS England Leeds
12 suppliers
- Thornton & Ross Huddersfield
- Tillomed Laboratories Luton
- Glenmark Pharmaceuticals Europe Middlesex
- Gilead Sciences London
- Amarox Middlesex
- Mercury Pharmaceuticals London
- Teva Castleford
- Zentiva Pharma London
- Accord Devon
- Drreddys Laboratories Cambridge
- Celix Pharma London
- Seacross Pharmaceuticals London
Description
Project title: NHS National Framework for Transition products commencing 1 October 2024Offer reference number: CM/TNS/24/5712Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.Potential periods of call-offs under the framework agreement: CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tabletsLot 1 CESW: 01/10/2024 to 30/09/2025 (12 months) Lot 2 NWLN: 01/10/2024 to 30/09/2025 (12 months) Lot 3 LSNE: 01/10/2024 to 31/05/2026 (20 months) CM/TNS/24/5712/02 - ImatinibLot 1 DSW: 01/10/2024 to 30/09/2025 (12 months) Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England
Lot Division
| 1 | CM/TNS/24/5712/01 CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tabletsLot 1 CESW: 01/10/2024 to 30/09/2025 (12 months) Lot 2 NWLN: 01/10/2024 to 30/09/2025 (12 months) Lot 3 LSNE: 01/10/2024 to 31/05/2026 (20 months) |
| 2 | CM/TNS/24/5712/02 CM/TNS/24/5712/02 - ImatinibLot 1 DSW: 01/10/2024 to 30/09/2025 (12 months) |
Award Detail
| 1 | Thornton & Ross (Huddersfield)
|
| 2 | Tillomed Laboratories (Luton)
|
| 3 | Glenmark Pharmaceuticals Europe (Middlesex)
|
| 4 | Gilead Sciences (London)
|
| 5 | Amarox (Middlesex)
|
| 6 | Mercury Pharmaceuticals (London)
|
| 7 | Teva (Castleford)
|
| 8 | Zentiva Pharma (London)
|
| 9 | Accord (Devon)
|
| 10 | Drreddys Laboratories (Cambridge)
|
| 11 | Celix Pharma (London)
|
| 12 | Seacross Pharmaceuticals (London)
|
| 13 | Teva (Castleford)
|
Renewal Options
Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months
Award Criteria
| PRICE | _ |
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Options are available.
- Award on basis of price.
Reference
- FTS 033646-2024